Pathways of oncogene-induced senescence in human melanocytic cells
about
RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma developmentRegulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanomaInterferon-γ induces senescence in normal human melanocytes.PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cellsCooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cells.Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma.Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberineMutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.Recent progress in genetics of aging, senescence and longevity: focusing on cancer-related genes.The role of mitogen- and stress-activated protein kinase pathways in melanoma.Narrowing the knowledge gaps for melanomaControversial aspects of oncogene-induced senescence.SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways.Ribonucleotide reductase and thymidylate synthase or exogenous deoxyribonucleosides reduce DNA damage and senescence caused by C-MYC depletion.Ras-induced ROS upregulation affecting cell proliferation is connected with cell type-specific alterations of HSF1/SESN3/p21Cip1/WAF1 pathways.Detection of Nucleotide Disbalance in Cells Undergoing Oncogene-Induced Senescence.The Immortal Senescence.New functions for the Snail family of transcription factors: Two-faced proteins.8-Cl-cAMP and PKA I-selective cAMP analogs effectively inhibit undifferentiated thyroid cancer cell growth.Regulation of cellular senescence via the FOXO4-p53 axis.Polycomb group proteins: New targets of anti-cancer therapy.
P2860
Q30657002-9EE785C3-E320-4D14-9DEA-CDF584DF78ADQ34346745-013DEE6F-576A-4CE4-B832-0C9F5CC10677Q35134926-8A1842EA-09FE-4D5F-807E-5CE30856B0F8Q35541658-07D4C107-1F40-4F76-B864-022E71F698C6Q35640301-190F2D9A-209D-4E05-8867-774FDF0B698FQ36339260-97835F63-13FA-40BB-B1A9-746F80AC8032Q36556350-900434D1-6EFB-42C3-8962-E00DCA0245BEQ36862768-F9307EE9-C9BD-496C-A0A1-1BB42CFD822DQ36926098-AA2CBFFB-0DD4-48B0-9DA1-FC1603DEEBF1Q37931402-9DC73644-150F-4907-96AF-BEB47C2981F1Q37984547-1B48E124-54ED-4608-B42B-05C70438D38EQ38055308-F14DEDE2-238B-4BCD-8148-32F82774AC07Q38262971-5AEBBCAA-78AB-41E6-BC93-49F43385ACD5Q39224402-A650A4EF-EB41-4165-A7FF-A5C07E437DD2Q39388968-80F8E0A1-0F8A-4B6F-9B19-0BBA2A5FA3C9Q41585228-9A62258C-3BC1-401B-B95E-96629F445C8EQ42380380-3DF9C808-7DE5-4B8B-AC5F-FF5DF7120CC3Q43006124-DBD9ED13-DFE4-407F-8673-B72F674E7C99Q51615486-8FD39F13-588A-4693-8221-B3D99604FB51Q52717506-F02DA2B0-1181-4EF9-8BB0-7430B1BC6821Q54658888-95D4CEC0-6847-4CB2-A8CB-0D43B0A0A4FA
P2860
Pathways of oncogene-induced senescence in human melanocytic cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathways of oncogene-induced senescence in human melanocytic cells
@en
Pathways of oncogene-induced senescence in human melanocytic cells.
@nl
type
label
Pathways of oncogene-induced senescence in human melanocytic cells
@en
Pathways of oncogene-induced senescence in human melanocytic cells.
@nl
prefLabel
Pathways of oncogene-induced senescence in human melanocytic cells
@en
Pathways of oncogene-induced senescence in human melanocytic cells.
@nl
P2860
P356
P1433
P1476
Pathways of oncogene-induced senescence in human melanocytic cells
@en
P2093
Mikhail A Nikiforov
Rajat Bansal
P2860
P304
P356
10.4161/CC.9.14.12251
P577
2010-07-03T00:00:00Z